Jane M. Meijlink

Jane M. Meijlink

Auto-generated profile, based on publicly available information

Jane M. Meijlink

International Painful Bladder Foundation, Naarden, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
TUTomohiro Ueda
Tomohiro Ueda
PHPhilip M. Hanno
Philip M. Hanno
RSRyoichi Saito
Ryoichi Saito
JMJane M. Meijlink
Jane M. Meijlink
NYNaoki Yoshimura
Naoki Yoshimura
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by suprapubic pain and lower urinary tract symptoms. Perhaps because of the heterogeneous nature of this disease and its multifactorial etiology, clinical trials in allinclusive populations of IC/BPS patients without phenotyping in the last decade have mainly failed to discover new therapeutic modalities of IC/BPS. Thus, phenotyping IC/BPS, aimed at identifying bladder-centric and/or bladder-beyond pathologies, including cystoscopic observation of Hunner or non-Hunner lesions of the bladder mucosa, is particularly important for the future of IC/BPS management. Based on recent discussions at international conferences, including the International Consultation on IC, Japan, it has been proposed that Hunner-lesion IC should be separated from other non-Hunner IC/BPS because of its distinct inflammatory profiles and epithelial denudation compared with non-Hunner IC/BPS. However, there are still no standard criteria for the diagnosis of Hunner lesions other than typical lesions, while conventional cystoscopic observations may miss atypical or small Hunner lesions. Furthermore, diagnosis of the bladder-centric phenotype of IC/BPS requires confirmation that identified mucosal lesions are truly a cause of bladder pain in IC/BPS patients. This review article discusses the current status of IC/BPS pathophysiology and diagnosis, as well as future directions of the proper diagnosis of bladder-centric IC/BPS, in which pathophysiological mechanisms other than those in inflammatory pathways, such as angiogenic and immunogenic abnormalities, could also be involved in both Hunner-lesion IC and non-Hunner IC/BPS. It is hoped that this new paradigm in the pathophysiological evaluation and diagnosis of IC/BPS could lead to pathology-based phenotyping and new treatments for this heterogeneous disease.

1 April 2014 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
JMJane M Meijlink
Jane M Meijlink

10 November 2023 in Continence
Verified
Journal Article
Open access
PHPhilip Hanno
Philip Hanno
MCMauro Cervigni
Mauro Cervigni
MCMyung Soo Choo
Myung Soo Choo
JCJ. Quentin Clemens
J. Quentin Clemens
MLMing-Huei Lee
Ming-Huei Lee
DGDaniela Gold
Daniela Gold
Interstitial cystitis and bladder pain syndrome are essentially interchangeable as there is no accepted definition that clearly delineates the interstitial cystitis syndrome from bladder pain syndrome. IC/BPS is generally agreed to be defined as chronic pelvic pain, pressure, or discomfort perceived to be related to the urinary bladder when accompanied by at least one other urinary symptom such as persistent urge to void or urinary frequency when in the absence of confusable diseases. The Consultation believes that patients who meet the definition and have a Hunner lesion should be considered to have a distinct confusable disease (Hunner lesion disease — HLD) and be managed accordingly. It follows that early cystoscopy is essential in establishing whether the diagnosis is HLD or IC/BPS. As no single treatment works well over time for a majority of patients, the treatment approach should be tailored to the specific symptoms of each patient and a multidisciplinary approach may be required. A reasonable diagnostic and treatment algorithm is offered by the Consultation. For methodology and the complete report of the committee with complete references, please refer to the 7th edition of the International Consultation on Urological Diseases Incontinence.

17 August 2017 in Urologia Journal
Verified
Journal Article
Closed access
JMJane M. Meijlink
Jane M. Meijlink
Patients with chronic pain, discomfort and other urinary symptoms related to bladder pain syndrome or urinary tract infections may experience severely diminished quality of life and psychological and social problems, including depression, anxiety, and a sense of helplessness and hopelessness. These patients require empathy, understanding and practical support to allow them to cope with their chronic bladder disorder.

10 July 2020 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
JMJane Meijlink
Jane Meijlink

1 October 2015
Verified
Journal Article
Open access
PDF file
JMJane M. Meijlink
Jane M. Meijlink
Patient-centred standardization in interstitial cystitis/bladder pain syndrome—a PLEA